annual current liabilities:
$309.92M+$212.54M(+218.25%)Summary
- As of today (September 17, 2025), PCRX annual total current liabilities is $309.92 million, with the most recent change of +$212.54 million (+218.25%) on December 31, 2024.
- During the last 3 years, PCRX annual current liabilities has fallen by -$211.20 million (-40.53%).
- PCRX annual current liabilities is now -40.53% below its all-time high of $521.12 million, reached on December 31, 2021.
Performance
PCRX Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$313.16M-$1.57M(-0.50%)Summary
- As of today (September 17, 2025), PCRX quarterly total current liabilities is $313.16 million, with the most recent change of -$1.57 million (-0.50%) on June 30, 2025.
- Over the past year, PCRX quarterly current liabilities has increased by +$220.47 million (+237.86%).
- PCRX quarterly current liabilities is now -39.91% below its all-time high of $521.12 million, reached on December 31, 2021.
Performance
PCRX quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
PCRX Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +218.3% | +237.9% |
| 3 y3 years | -40.5% | +135.2% |
| 5 y5 years | +187.8% | +343.7% |
PCRX Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -40.5% | +218.3% | -0.5% | +237.9% |
| 5 y | 5-year | -40.5% | +218.3% | -39.9% | +343.7% |
| alltime | all time | -40.5% | +2089.3% | -39.9% | +2366.3% |
PCRX Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $313.16M(-0.5%) |
| Mar 2025 | - | $314.73M(+1.6%) |
| Dec 2024 | $309.92M(+218.2%) | $309.92M(+1.1%) |
| Sep 2024 | - | $306.40M(+230.6%) |
| Jun 2024 | - | $92.69M(-0.8%) |
| Mar 2024 | - | $93.44M(-4.0%) |
| Dec 2023 | $97.38M(-34.1%) | $97.38M(+4.0%) |
| Sep 2023 | - | $93.66M(-14.0%) |
| Jun 2023 | - | $108.91M(+10.3%) |
| Mar 2023 | - | $98.70M(-33.2%) |
| Dec 2022 | $147.77M(-71.6%) | $147.77M(+12.4%) |
| Sep 2022 | - | $131.53M(-1.2%) |
| Jun 2022 | - | $133.18M(-56.3%) |
| Mar 2022 | - | $305.07M(-41.5%) |
| Dec 2021 | $521.12M(+105.7%) | $521.12M(+130.8%) |
| Sep 2021 | - | $225.79M(-1.3%) |
| Jun 2021 | - | $228.69M(-1.5%) |
| Mar 2021 | - | $232.08M(-8.4%) |
| Dec 2020 | $253.33M(+135.3%) | $253.33M(+193.6%) |
| Sep 2020 | - | $86.27M(+22.2%) |
| Jun 2020 | - | $70.58M(-12.1%) |
| Mar 2020 | - | $80.31M(-25.4%) |
| Dec 2019 | $107.67M(+77.5%) | $107.67M(+12.3%) |
| Sep 2019 | - | $95.84M(+15.5%) |
| Jun 2019 | - | $83.00M(+40.7%) |
| Mar 2019 | - | $58.99M(-2.8%) |
| Dec 2018 | $60.66M(+7.9%) | $60.66M(+11.3%) |
| Sep 2018 | - | $54.52M(+2.8%) |
| Jun 2018 | - | $53.02M(+9.6%) |
| Mar 2018 | - | $48.37M(-14.0%) |
| Dec 2017 | $56.22M | $56.22M(+7.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2017 | - | $52.34M(-9.0%) |
| Jun 2017 | - | $57.51M(+26.0%) |
| Mar 2017 | - | $45.65M(+1.8%) |
| Dec 2016 | $44.84M(-70.1%) | $44.84M(-69.5%) |
| Sep 2016 | - | $146.83M(-2.4%) |
| Jun 2016 | - | $150.44M(+2.9%) |
| Mar 2016 | - | $146.14M(-3.7%) |
| Dec 2015 | $149.79M(+7.0%) | $151.68M(+4.3%) |
| Sep 2015 | - | $145.41M(-0.0%) |
| Jun 2015 | - | $145.47M(+6.6%) |
| Mar 2015 | - | $136.45M(-2.5%) |
| Dec 2014 | $140.01M(+14.8%) | $140.01M(+3.5%) |
| Sep 2014 | - | $135.22M(+4.4%) |
| Jun 2014 | - | $129.51M(+6.5%) |
| Mar 2014 | - | $121.59M(-0.3%) |
| Dec 2013 | $121.94M(+761.4%) | $121.94M(+4.2%) |
| Sep 2013 | - | $116.97M(+638.7%) |
| Jun 2013 | - | $15.84M(+24.7%) |
| Mar 2013 | - | $12.70M(-10.3%) |
| Dec 2012 | $14.16M(-55.6%) | $14.16M(-28.6%) |
| Sep 2012 | - | $19.83M(+30.1%) |
| Jun 2012 | - | $15.24M(-20.5%) |
| Mar 2012 | - | $19.16M(-40.0%) |
| Dec 2011 | $31.91M(+95.5%) | $31.91M(+79.0%) |
| Sep 2011 | - | $17.83M(+2.0%) |
| Jun 2011 | - | $17.48M(-11.1%) |
| Mar 2011 | - | $19.66M(+20.5%) |
| Dec 2010 | $16.32M(+13.2%) | $16.32M(+18.2%) |
| Sep 2010 | - | $13.81M(-2.4%) |
| Jun 2010 | - | $14.14M(-1.9%) |
| Dec 2009 | $14.42M(-15.3%) | $14.42M |
| Dec 2008 | $17.02M | - |
FAQ
- What is Pacira BioSciences, Inc. annual total current liabilities?
- What is the all time high annual current liabilities for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. annual current liabilities year-on-year change?
- What is Pacira BioSciences, Inc. quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. quarterly current liabilities year-on-year change?
What is Pacira BioSciences, Inc. annual total current liabilities?
The current annual current liabilities of PCRX is $309.92M
What is the all time high annual current liabilities for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high annual total current liabilities is $521.12M
What is Pacira BioSciences, Inc. annual current liabilities year-on-year change?
Over the past year, PCRX annual total current liabilities has changed by +$212.54M (+218.25%)
What is Pacira BioSciences, Inc. quarterly total current liabilities?
The current quarterly current liabilities of PCRX is $313.16M
What is the all time high quarterly current liabilities for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high quarterly total current liabilities is $521.12M
What is Pacira BioSciences, Inc. quarterly current liabilities year-on-year change?
Over the past year, PCRX quarterly total current liabilities has changed by +$220.47M (+237.86%)